Evidence map›Paper›PMID 32660036›Full record

ReviewCancers2020

Desmoid-Type Fibromatosis.

Dorian Yarih Garcia-Ortega, Karla Susana Martín-Tellez, Mario Cuellar-Hubbe, Héctor Martínez-Said, Alethia Álvarez-Cano, Moises Brener-Chaoul, Jorge Adán Alegría-Baños, Jorge Luis Martínez-Tlahuel

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Guideline
  2. GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESSQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Injection lipolysis-induced abdominal fibrosis mimicking desmoid fibromatosis.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
  10. Article
  11. Article
  12. Desmoid fibromatosis in a child with DICER1-related tumor predisposition.Virchows Archiv : an international journal of pathology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dorian Yarih Garcia-OrtegaNational Cancer Institute (Instituto Nacional de Cancerologia), Mexico City 14080, Mexico.
Karla Susana Martín-TellezHospital Angeles de las Lomas, Huixquilucan, Estado de Mexico 52763, Mexico.
Mario Cuellar-HubbeNational Cancer Institute (Instituto Nacional de Cancerologia), Mexico City 14080, Mexico.
Héctor Martínez-SaidNational Cancer Institute (Instituto Nacional de Cancerologia), Mexico City 14080, Mexico.
Alethia Álvarez-CanoOncare Cancer Center, Monterrey Nuevo Leon 66220, Mexico.ORCID 0000-0002-2485-3409
Moises Brener-ChaoulHospital Angeles de las Lomas, Huixquilucan, Estado de Mexico 52763, Mexico.
Jorge Adán Alegría-BañosNational Cancer Institute (Instituto Nacional de Cancerologia), Mexico City 14080, Mexico.
Jorge Luis Martínez-TlahuelNational Cancer Institute (Instituto Nacional de Cancerologia), Mexico City 14080, Mexico.
Instituto Nacional de Cancerología · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Desmoid tumors represent a rare entity of monoclonal origin characterized by locally aggressive behavior and inability to metastasize. Most cases present in a sporadic pattern and are characterized by a mutation in the CTNNB1 gene; while 5-15% show a hereditary pattern associated with APC gene mutation, both resulting in abnormal β-catenin accumulation within the cell. The most common sites of presentation are the extremities and the thoracic wall, whereas FAP associated cases present intra-abdominally or in the abdominal wall. Histopathological diagnosis is mandatory, and evaluation is guided with imaging studies ranging from ultrasound, computed tomography or magnetic resonance. Current approaches advocate for an initial active surveillance period due to the stabilization and even regression capacity of desmoid tumors. For progressive, symptomatic, or disabling cases, systemic treatment, radiotherapy or surgery may be used. This is a narrative review of this uncommon disease; we present current knowledge about molecular pathogenesis, diagnosis and treatment.

Indexed as

aggressive fibromatosisdesmoiddesmoid tumordesmoid-type fibromatosisβ-catenin

Identifiers

PMID32660036
PMCPMC7408653
OpenAlexW3041476349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.